双重表观遗传疗法加化学疗法在外围T细胞淋巴瘤与T毛囊辅助体现型的T细胞淋巴瘤
Suheil Albert Atallah-Yunes1, Yucai Wang1
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Med (New York, N.Y.)
|November 9, 2024
概括
双重表观遗传疗法与阿扎西提丁和奇达胺显示安全性和有效性在复发/耐药的外围T细胞淋巴瘤. 组合疗法,特别是在血管免疫芽细胞T细胞淋巴瘤中,需要进一步研究化疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 复发性/难治性外围T细胞淋巴瘤 (PTCL) 是一个重大的临床挑战.
- 需要新的治疗策略来改善PTCL患者的治疗结果.
研究的目的:
- 评估阿扎西提丁和奇达胺联合治疗复发/耐药PTCL患者的安全性和有效性.
- 探索将Gemox化疗添加到这种双重表观遗传疗法的潜在好处.
主要方法:
- 采用了一个非随机的II期研究设计.
- 这项研究包括患有复发/耐药PTCL的患者,重点关注血管免疫细胞T细胞淋巴瘤 (AITL) 亚组.
- 治疗包括阿扎西蒂丁和奇达胺,可选添加GemOx化疗.
主要成果:
- 阿扎西蒂丁和奇达胺的组合表明了有利的安全性.
- 双重表观遗传疗法在整体PTCL队列中被发现是有效的.
- 在血管免疫芽细胞T细胞淋巴瘤子组中观察到特别有前途的反应.
结论:
- 用azacitidine和chidamide进行双重表观遗传疗法是复发/耐药PTCL的安全和有效的治疗选择.
- 血管免疫发育T细胞淋巴瘤子组可能从这种方法中获得显著的益处.
- 需要对这种疗法添加化疗进行进一步的研究.
更多相关视频
07:39Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry
Published on: January 7, 2019
12.2K
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.7K
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K